ABCS training for Cardiovascular Risk
This study is evaluating whether a program can help improve the use of evidence-based interventions for individuals with heart disease.
See full descriptionAbout the trial for Cardiovascular Risk
Treatment Groups
This trial involves 2 different treatments. ABCS Training is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether ABCS training will improve 1 primary outcome in patients with Cardiovascular Risk. Measurement will happen over the course of 12 months.
Who is running the study
Principal InvestigatorPatient Q & A Section
Can cardiovascular risk be cured?
Cardiovascular risk can be cured. However, the mechanism for this is unknown; for this reason the use of [cardiovascular risk medications and healthy lifestyle choices] to reduce risk seems to be more effective at reducing heart disease and premature death than [new medications and lifestyle changes].
How many people get cardiovascular risk a year in the United States?
Cardiovascular risk in the USA, including cardiovascular risk from all causes, is much greater than that reported previously, including the United Kingdom, in which it was estimated at around 90 cases a year. Results from a recent paper confirm the value, and emphasize the need, of cardiovascular disease prevention programmes. The current rate of cardiovascular morbidity and mortality in the USA is probably one of the highest in the world.
What causes cardiovascular risk?
Age has a strong association with most of the cardiovascular risk factors studied, in particular with cholesterol. Sex has an independent association with LDL, total and triglyceride levels, and hs-CRP. High blood pressure appears to be a significant contributing factor, especially at young ages. The role of obesity has not been studied. It is important to reduce the prevalence of obesity in adolescents, especially in boys. A high-quality clinical trial to assess the impact of lifestyle modification strategies on lipids and BP will assist in the reduction of cardiovascular risk in adolescents.
What is cardiovascular risk?
There is a lack of evidence of the value of routine lipid screening in a population with moderate-to-high CVD risk, particularly if there are no clinical indications of dyslipidemia.
What are common treatments for cardiovascular risk?
The cardiovascular risk profile of a country is determined by its medical infrastructure and availability/cost issues of drugs. A country can improve its cardiovascular risk profile by implementing a number of strategies that include (1) increased coverage of CVD prevention and (2) greater access to CVD medications. A country should consider adopting the strategies defined as feasible, sustainable, affordable, practical, and effective and should evaluate their impact on its cardiovascular risk profile. This evaluation can help them define whether their strategy has improved their cardiovascular risk profile.
What are the signs of cardiovascular risk?
The most important signs of cardiovascular risk are raised blood pressure, raised cholesterol, increased blood sugar and, in the case of diabetes, loss of limbs and feet.
How serious can cardiovascular risk be?
Cardiovascular events are a major cause of death in the general population. In order to reduce cardiovascular mortality, prevention of cardiovascular events is vital. Despite numerous risk factor studies, the risk of cardiovascular events has persisted, and current treatment protocols have demonstrated a limited effect. The Power tool can help you search for clinical trial trials that are tailored to your treatment, medical condition or location. On a daily basis, the [Cardiology Unit at Memorial Sloan-Kettering Cancer Center] actively provides free access to your cardiovascular risk profiles in order to help you make the best choices about your ongoing preventive health care.
Has abcs training proven to be more effective than a placebo?
The Abc Training Program was effective at improving several cardiovascular risk factors. The intervention appears to be more effective with higher level learners and may need to be expanded. This may be due to the increased exposure to Abc training of the participants.
How does abcs training work?
The abcs intervention had modest effects on exercise capacity and arterial blood pressure in moderately impaired subjects. Results from a recent paper imply that it is possible to improve exercise capacity with exercise training of moderate intensity in moderately impaired subjects with type 2 hypertension.
Who should consider clinical trials for cardiovascular risk?
Physicians must consider the baseline risk of CAD, CV risk at diagnosis, the benefit-risk of the intervention, and the cost to the patient for participating in clinical trials when deciding regarding whether to participate in a clinical trial.
Have there been other clinical trials involving abcs training?
In a recent study, findings indicate that a short period of training can reduce the likelihood of incident CVD, which is a leading cause of death. Such a training method needs to be thoroughly studied so that its effects can be replicated.
What is abcs training?
In spite of the [obesity epidemic], the level of physical activity of most people remains low. As we move into a period of ageing populations, the risk of morbidity and mortality will increase due to the prevalence of heart failure and other cardiovascular diseases. A better understanding of risk factors will enable us to develop methods of prevention. The [ABCS] provides the means for this.